Mark Kozloff to Neuropilin-2
This is a "connection" page, showing publications Mark Kozloff has written about Neuropilin-2.
Connection Strength
0.030
-
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors. Invest New Drugs. 2014 Aug; 32(4):700-9.
Score: 0.030
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.